Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Miguel Angel Berciano-Guerrero"'
Autor:
Mora Guardamagna, Miguel-Angel Berciano-Guerrero, Beatriz Villaescusa-González, Elisabeth Perez-Ruiz, Javier Oliver, Rocío Lavado-Valenzuela, Antonio Rueda-Dominguez, Isabel Barragán, María Isabel Queipo-Ortuño
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 19, p 11990 (2022)
Gut microbiome (GM) and its either pro-tumorigenic or anti-tumorigenic role is intriguing and constitutes an evolving landscape in translational oncology. It has been suggested that these microorganisms may be involved in carcinogenesis, cancer treat
Externí odkaz:
https://doaj.org/article/32060d15bd2248a0a5b59a949493e66b
Autor:
Miguel-Angel Berciano-Guerrero, Mora Guardamagna, Elisabeth Perez-Ruiz, Jose-Miguel Jurado, Isabel Barragán, Antonio Rueda-Dominguez
Publikováno v:
Life, Vol 12, Iss 9, p 1302 (2022)
Metastatic melanoma (MM) is a pathological entity with a very poor prognosis that, until a few decades ago, had a low response rate to systemic treatments. Fortunately, in the last few years, new therapies for metastatic melanoma have emerged. Curren
Externí odkaz:
https://doaj.org/article/fbe0ab79699b4547b29a3613b3c82678
Autor:
Miguel-Angel Berciano-Guerrero, Rocío Lavado-Valenzuela, Aurelio Moya, Luis delaCruz-Merino, Fátima Toscano, Javier Valdivia, Victoria Castellón, Fernando Henao-Carrasco, Pilar Sancho, Juan-Luis Onieva-Zafra, Ismael Navas-Delgado, Antonio Rueda-Dominguez, Elisabeth Perez-Ruiz, Emilio Alba
Publikováno v:
Biomedicines, Vol 10, Iss 2, p 284 (2022)
Targeted therapy in metastatic melanoma often achieves a major tumour regression response and significant long-term survival via the release of antigens that reinduce immunocompetence. The biomarkers thus activated may guide the prediction of respons
Externí odkaz:
https://doaj.org/article/18a4039dc9494c71a63c0c1a8eff1060
Publikováno v:
Cancer Medicine. 11:40-46
Locoregional recurrence of differentiated thyroid cancer (DTC) occurs in 20% of thyroid cancer patients. Currently, there are many strategies for management of locoregional recurrence of DTC that lead to local control of the disease. The introduction
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71a10e3c0e1fcdeed267fa7c5ff10211
https://doi.org/10.1002/cam4.5108
https://doi.org/10.1002/cam4.5108
Autor:
Francisca Palomares, Cristobalina Mayorga, Antonio Rueda, Maria Salas, Tahia D. Fernandez, Miguel-Angel Berciano-Guerrero, María José Torres
Publikováno v:
Allergy. 76:2285-2288
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6004d44959aaac7eae9b36a58871fc57
https://doi.org/10.1111/all.14807
https://doi.org/10.1111/all.14807
Autor:
Pilar Piñeiro, Manuel Cobo, Qingyang Xiao, Miguel-Angel Berciano-Guerrero, Isabel Barragan, Emilio Alba, André Nobre, Volker M. Lauschke
Publikováno v:
Journal of Clinical Medicine
Journal of Clinical Medicine, Vol 9, Iss 1, p 286 (2020)
PubMed Central
Journal of Clinical Medicine, Vol 9, Iss 1, p 286 (2020)
PubMed Central
Checkpoint inhibitor therapy constitutes a promising cancer treatment strategy that targets the immune checkpoints to re-activate silenced T cell cytotoxicity. In recent pivotal trials, immune checkpoint blockade (ICB) demonstrated durable responses
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9ff4566701d6e88dc488d66f4134fbb
Autor:
Manuel Cobo, Elena Gallego, Isabel Barragan, Maria Rosario Chica-Parrado, Alicia Garrido-Aranda, Iñaki Comino, Alfonso Pérez Sánchez, Javier Oliver, Maria Jose Lozano, Aurora Laborda-Illanes, Juan Luis Onieva, Pedro Jimenez, Daniel Prieto, Cynthia Robles-Podadera, Miguel Angel Berciano-Guerrero, Martina Alvarez, Vanessa de Luque, Emilio Alba
Publikováno v:
Cancer Research. 80:281-281
Melanoma comprises a variety of malignant cell types from the skin, the mucous membranes, and the pigmented cells of the eye. Its incidence and mortality rates continue to rise worldwide, mainly driven by increased ultraviolet light exposure. Althoug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cdf41454b1f74af23b57f10e1ba8b404
https://doi.org/10.1158/1538-7445.am2020-281
https://doi.org/10.1158/1538-7445.am2020-281
Autor:
Pablo Ayala de Miguel, L. Bellido, Alfonso Berrocal, Lourdes Gutierrez Gutierrez Sanz, Enrique Espinosa, Guillermo Crespo, Pablo Cerezuela Fuentes, Jose Luis Manzano Mozo, Javier Medina, Salvador Martín-Algarra, Almudena García Castaño, Luis Antonio Fernandez-Morales, Margarita Majem, Miguel Angel Berciano Guerrero, Carlos Aguado De La Rosa, Eva Muñoz-Couselo, Rafael López Castro, Ainara Soria, Teresa Puertolas, Ivan Marquez-Rodas
Publikováno v:
Journal of Clinical Oncology. 38:e22022-e22022
e22022 Background: In the past decade, melanoma treatment has improved due to the advances in targeted therapy and immunotherapy. There are few data, however, about the treatment elections and the outcomes of the patients in the real world setting, s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1e787da954721da70c4fcfc5ea1437a4
https://doi.org/10.1200/jco.2020.38.15_suppl.e22022
https://doi.org/10.1200/jco.2020.38.15_suppl.e22022
Autor:
Constanza Gallardo, Elisabeth Perez Ruiz, Martina Alvarez, Aurora Laborda-Illanes, Juan Luis Onieva Zafra, Jose Antonio Bernal, Pedro Jimenez Gallego, Manuel Cobo Dols, Isabel Barragan, Javier Oliver, R. Villatoro, Miguel-Angel Berciano-Guerrero, Marilina García-Aranda, Belen Sojo
Publikováno v:
Journal of Clinical Oncology. 38:e21603-e21603
e21603 Background: Despite the efforts, there is still no biomarker that is able to predict the response and / or that can be used in the monitoring of patients treated with check-points inhibitors (ICI). Methods: Prospective study of a panel of bloo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::88bc096364a633c87cfd969a6e92f1bb
https://doi.org/10.1200/jco.2020.38.15_suppl.e21603
https://doi.org/10.1200/jco.2020.38.15_suppl.e21603
Autor:
Miguel Angel Berciano-Guerrero, Rocio Lavado-Valenzuela, Ismael Navas-Delgado, José F. Aldana-Montes, Alicia Fernandez-Rovira
Publikováno v:
RIUMA. Repositorio Institucional de la Universidad de Málaga
instname
instname
Melanoma is a highly immunogenic tumor. Therefore, in recent years physicians have incorporated drugs that alter the immune system into their therapeutic arsenal against this disease, revolutionizing in the treatment of patients in an advanced stage
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee805632a9251682fb81938bd1973f80
http://orcid.org/0000-0001-7819-5416
http://orcid.org/0000-0001-7819-5416
